Sign Up to like & get
recommendations!
1
Published in 2023 at "Neuropsychopharmacology reports"
DOI: 10.1002/npr2.12332
Abstract: AIM Repetitive transcranial magnetic stimulation (rTMS) is one of the most effective and minimally invasive treatments for treatment-resistant depression (TRD). However, the mechanism underlying the therapeutic effects of rTMS in patients with TRD remains unclear.…
read more here.
Keywords:
rtms;
depression;
strem2;
rtms patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2018.10.007
Abstract: AIMS No cohort study has examined the pathological significance of triggering receptor expressed on myeloid cell 2 (TREM2), a cell surface receptor expressed on myeloid lineage cells, and its soluble form, sTREM2, in insulin resistance…
read more here.
Keywords:
expressed myeloid;
strem2;
receptor expressed;
insulin resistance ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Neurobiology of Disease"
DOI: 10.1016/j.nbd.2022.105630
Abstract: Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor expressed by macrophages and microglia in the central nervous system (CNS). TREM2 has attracted a lot of interest in the past decade…
read more here.
Keywords:
soluble trem2;
strem2;
active player;
disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Nature Communications"
DOI: 10.1038/s41467-019-09118-9
Abstract: Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial surface receptor genetically linked to the risk for Alzheimer’s disease (AD). A proteolytic product, soluble TREM2 (sTREM2), is abundant in the cerebrospinal fluid and…
read more here.
Keywords:
alzheimer disease;
soluble trem2;
strem2;
model ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.aau2291
Abstract: Common variants in the microglia-specific MS4A gene cluster modify risk for late-onset Alzheimer’s disease and modulate extracellular soluble TREM2. TREM2 takes center stage Genetic variants in triggering receptor expressed on myeloid cells 2 (TREM2) are…
read more here.
Keywords:
risk;
alzheimer disease;
ms4a gene;
disease ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "EMBO Molecular Medicine"
DOI: 10.15252/emmm.202216987
Abstract: Microglial activation occurs early in Alzheimer's disease (AD) and previous studies reported both detrimental and protective effects of microglia on AD progression. Here, we used CSF sTREM2 to investigate disease stage‐dependent drivers of microglial activation…
read more here.
Keywords:
disease;
alzheimer disease;
strem2;
glucose hypermetabolism ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.843828
Abstract: Objective Cognitive impairment is a common comorbidity in patients with obstructive sleep apnea (OSA) that leads to poor quality of life and a heavier medical burden. However, the assessment and longitudinal tracking of cognitive impairment…
read more here.
Keywords:
mild cognitive;
cognitive impairment;
serum strem2;
strem2 ... See more keywords